Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
19
-
Total 13F shares, excl. options
-
61.9K
-
Shares change
-
+15.6K
-
Total reported value, excl. options
-
$461K
-
Value change
-
+$115K
-
Number of buys
-
8
-
Number of sells
-
-6
-
Price
-
$7.39
Significant Holders of MiNK Therapeutics, Inc. - COM NEW (INKT) as of Q2 2025
20 filings reported holding INKT - MiNK Therapeutics, Inc. - COM NEW as of Q2 2025.
MiNK Therapeutics, Inc. - COM NEW (INKT) has 19 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 61.9K shares
.
Largest 10 shareholders include VANGUARD GROUP INC (23.7K shares), Longbow Finance SA (16.7K shares), GEODE CAPITAL MANAGEMENT, LLC (11.5K shares), BlackRock, Inc. (7.42K shares), WELLS FARGO & COMPANY/MN (849 shares), BANK OF AMERICA CORP /DE/ (568 shares), TOTAL INVESTMENT MANAGEMENT INC (500 shares), UBS Group AG (284 shares), Covestor Ltd (131 shares), and OSAIC HOLDINGS, INC. (120 shares).
This table shows the top 19 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.